Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
WellChoice was a leading health insurance company that operated primarily through its subsidiary, Empire BlueCross BlueShield, serving the New York metropolitan area. The company provided a diverse range of managed care and indemnity insurance products to millions of members, including individuals and large employer groups. As a major healthcare payer, WellChoice focused on managing healthcare costs and providing access to a broad network of medical providers. The company transitioned from a non-profit to a for-profit entity in 2002, launching a successful IPO on the New York Stock Exchange. In 2005, WellChoice was acquired by WellPoint (now Elevance Health) in a multi-billion dollar transaction that consolidated its position in the national insurance market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on WellChoice.